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Background: Oxidative stress due to abnormal induction of reactive oxygen species (ROS) molecules is believed to
be involved in the etiology of many diseases. Evidences suggest that ROS is involved in nephrotoxicity through
frequent exposure to industrial toxic agents such as thioacetamide (TAA). The current investigation was designed to
explore the possible protective effects of the leaves of Vitex negundo(VN) extract against TAA-induced
nephrotoxicity in rats.
Methods: Twenty four Sprague Dawleyrats were divided into four groups: (A) Normal control, (B) TAA (0.03% w/v in
drinking water), (C) VN100 (VN 100 mg/kg + TAA) and (D) VN300 (VN 300 mg/kg + TAA). Blood urea and serum
creatinine levels were measured,supraoxide dismutase (SOD), catalase (CAT) and malondialdehyde (MDA) levels of
renal tissue were assayed. Histopathological analysis together with the oxidative stress nicotinamide adenine
dinucleotide phosphate (NADPH) oxidase p22phox in kidney sections were examined in all experimental groups.
Results: Blood urea and serum creatinine levels were increased in TAA group as a result of the nephrotoxicity
compared to the VN100 and VN300 groups where, the levels were significantly decreased (p < 0.05). Renal MDA
level was significantly decreased (p < 0.05) in the VN-treated groups with increased CAT and SOD activities
compared to the TAA group. Light microscopic examination of renal tissues stained by H&E stain and Masson’s
Trichrome for TAA-treated groups revealed severe histopathological changes, whereas specimens obtained from
VN-treated groups showed only mild changes. These findings were supported by immunohistochemical results.
Conclusions: VN extract acts as a natural potent antioxidant to prevent ongoing TAA-induced nephrotoxicity in
rats, both biochemically and morphologically.
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Kidneys are highly vulnerable to damage caused by re-
active oxygen species (ROSs), likely due to oxidative
stress by polyunsaturated fatty acids in the composition
of renal lipids [1]. This damage can also be caused by a
high volume of blood flowing through it, and filtering
large amounts of toxins, which can concentrate in kid-
ney lobules [2]. The kidney’s response to toxicants var-
ies by multiple morphological patterns beginning with
tubular or interstitial changes to nephropathy [3]. It has* Correspondence: normadiah_mk@um.edu.my
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reproduction in any medium, provided the orbeen strongly implicated that (NADPH) oxidase, as a
major source of ROSs production in the kidney [4]
could have a role the in development of renal oxidative
damage.
Nephrotoxicity is a poisonous effect due to drugs and its
overdose on the kidneys. Thioacetamide (TAA) is an or-
ganic compound with the formula CH3CSNH2. It is ori-
ginally used as a fungicide, and is a potent hepatotoxin [5].
It can serve as a source of sulphur in the synthesis of or-
ganic compounds such as rubber chemicals, curing agents,
cross linking agents, metallurgy, pesticides, and pharma-
ceuticals [5]. TAA is the most potent nephrotoxic sub-
stance because of its rapid elimination and cumulative
injury when it is given intermittently,presumably by freed. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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induced tissue damage suggest that TAA is metabolized
by the mixed function oxidase system to its toxic metabo-
lites sulfine (sulfoxide) and sulfene (sulfone)which are then
distributed among several organs,including plasma, liver,
kidney, bone marrow, adrenals and other tissues [7]. Later,
TAA undergoes an extensive metabolism to acetate and it
is excreted through the urine within 24 hours [5,8].
Vitex negundo (VN) is commonly called five leaved
chaste tree. It is a large aromatic shrub or small and slen-
der with quadrangular branchlets, about 2 to 5 m in
height, distributed mainly in tropical to temperate regions,
especially in Malaysia, India at the warmest zones and
Western Himalayas [9].
The leaves have a typical five foliolate pattern in pal-
mate arrangement measuring4-10 cm long and bluish
purple in colour which become dark when ripened. The
whole parts of the plant have shown to be a potent
source of natural antioxidants [10], 1, 2 di-substituted
idopyranose, the isolated compound from VN extract
has shown protection of hepatocytes, nephrocytes and
pancreatic β-cells in streptozotocin-induced diabetes,
probably by its action against NF-kB and induced-nitric
oxide synthase iNOS mediated inflammation [11]. A
preliminary acute toxicity study of ethanolic leaf extract
of VN in albino rats by oral rout carried out by Tandon,
2005 [12] found it to be practically nontoxic, as its
LD50 dose was recorded as 7.58 g/Kg body weight with
no histomorphological changes in liver, kidney, stom-
ach, heart and lung at any dose of the extract studied.
VN has various traditional uses in treating stomach-
ache, eye disease, inflammation, enlargement of spleen,
bronchitis, asthma and painful teething in children. It is
also used as an antihelmintic, promoting hair growth
[13], and the juice of the leaves used in treating ulcers
and swelling of joints [14]. Literature review reveals that
the plant of VN possesses analgesic and antinociceptive
activity [15], hepatoprotective activity against TAA [16],
antituberculardrugs [12], CCl4 [17] and Ibuprofen via
inhibition of lipid peroxidation [18].
In this study, VN extract was utilized in a rat model to
evaluate its possible protective effects on TAA-induced
nephrotoxicity. Data were collected on serum creatinine
level, blood urea level, kidney and body weight ratio,
glutathione content, and lipid peroxidation in the kidney
tissues, as well as determination of p22phox expression
and histopathological changes in the kidneys after ad-
ministering VN extract in the adult male SD rats.
Methods
Collection and preparation of plant extract
Fresh leaves of VN plant were obtained from Kampung
Baru, Sungai Ara, Penang, Malaysia. The botanical identity
was determined and authenticated in the Department ofPharmacy, Faculty of Medicine, University Malaya, Kuala
Lumpur, Malaysia with voucher specimen number (KLU
34968). The plant was dried and grounded to a fine pow-
der. Next, the powder was homogenized in 95% ethanol at
a ratio of 1:10 of plant to ethanol, and left to soak for four
days at 25°C with occasional shaking and stirring. Later,
the mixture was filtered through filter paper, and the
resulting liquid was concentrated at a reduced pressure at
45°C to obtain a dark gummy–green extract. The percent-
age yield of VN crude extract was 18%. The extract was
then dissolved in Tween 20 (10% w/v) and administered
orally to rats in concentrations of 100 and 300 mg/kg
body weight.
Preparation of TAA
TAA (from Sigma-Aldrich, Switzerland) and all other
chemicals used were of analytical grade and purchased
mostly from Sigma-Aldrich and Fisher. TAA stock solu-
tion was prepared by dissolving30 mg pure TAA which
is in crystal form in 100 ml distilled water (0.03% w/v)
until all the crystals were dissolved. The solution was
given to the rats as their daily drinking water [19].
Experimental animals
A healthy adult male Sprague Dawley rats weighing 180–
200 gm were obtained from the Animal House Unit, Fac-
ulty of Medicine, University of Malaya, Malaysia. They
were kept in wire-bottomed cages at 25 ± 3°C, at 50–60%
humidity, and a 12 h light-dark cycle for at least a week be-
fore the experiment. They were maintained under standard
housing conditions with free access to a standard diet and
water ad libitum during the experiment. The experimental
protocol was approved by the Institutional Animal Care
and Use Committee, University of Malaya (UM IACUC)
with an ethical no. ANA/18/05/2012/FAAK. Throughout
the experiment, all criteria for taking care of animals pre-
pared by the National Academy of Sciences and outlined
in the “Guide for the Care and Use of laboratory Animals”
were compiled [20].
The animals were randomly divided into four experimen-
tal groups, with each group consisting of six rats, and given
the following treatments: Group A: Normal control group,
received per oral treatment of 10% Tween 20 (5 ml/kg)
daily for 12 weeks; Group B: TAA group, received TAA
0.03% w/v in drinking water daily for 12 weeks; Group C:
VN100 group, received TAA 0.03% w/v in drinking water
and 100 mg/kg body weight of VN extract daily for
12 weeks; Group D: VN300 group,received TAA 0.03% w/v
in drinking water and 300 mg/kg body weight of VN ex-
tract daily for 12 weeks.
The body weights of the animals were recorded weekly
throughout the experimental period starting from Day 0.
At the end of the 12th week, the rats were sacrificed
24 hours after the last treatment followed by overnight
Table 1 Effect of VN on body and kidney weights
Group Body weight (g) Kidney weight (g)
Normal control 219.8 ± 29.88** 0.95 ± 0.23
TAA 177.5 ± 7.1* 0.93 ± 0.119
VN100 + TAA 199.3 ± 15.98 0.94 ± 0.22
VN300 + TAA 204.3 ± 10.70 0.99 ± 0.29
Data were stated as mean ± SEM. Means with different superscripts are
significantly different. *P < 0.05 versus normal control group and **P < 0.05
versus TAA group.
Table 2 Effect of VN on blood urea and serum
creatininelevels
Group Urea (mmol/L) Creatinine (mol/L)
Normal control 4.46 ± 0.45** 23 ± 1.7**
TAA 8.73 ± 1.31* 52.3 ± 7.5*
VN100 + TAA 6.28 ± 0.59*,** 35.66 ± 7.3*,**
VN300 + TAA 5.73 ± 0.973** 29.33 ± 3.4**
Data were stated as mean ± SEM. Means with different superscripts are
significantly different. *P < 0.05 versus normal control group and **P < 0.05
versus TAA control group.
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jection of 50 mg/kg ketamine mixed with xylazine 5 mg/
kg. Blood samples were collected and serum was obtained
for estimation of creatinine and blood urea levels. Kidney
samples were dissected, trimmed of connective tissues,
washed using normal saline to eliminate blood contamin-
ation, dried by blotting with filter paper and weighed. The
kidneys were excised into two halves. One-half was kept in
isotonic formalin for histopathological assessment and the
other half was kept in the freezer under -80°C for prepar-
ing kidney homogenate for the malondialdehyde (MDA),
catalase (CAT) and supraoxide dismutase(SOD) assays.
Assessment of renal function
A blood sample was withdrawn through the jugular vein
and collected into a plain tube with activated gel for detec-
tion of urea and creatinine levels. The samples were
allowed to clot, centrifuged and the serum samples were
sent for analysis using a standard automated technique in
the Central Diagnostic Laboratory (CDL), University of
Malaya Medical Centre, according to the procedures de-
scribed by the manufacturers.
Preparation of kidney homogenates
Kidney homogenates (10% w/v) were prepared by hom-
ogenizing kidney tissue in cold 50 mM potassium phos-
phate buffer saline (pH 7.4) using a tissue homogenizer
(DAIHAN Sci., Seoul, Korea). The cell debris was removed
by centrifugation at 4500 rpm for 15 minutes at 4°C using a
refrigerated centrifuge Rotofix 32 (Hettich Zentrifugen,
Germany). The supernatant was used for estimating the
following in vivo antioxidant using commercially available
kits (Cayman Chemical Company, USA): (MDA) or thio-
barbituric acid reactive substance (TBARS) (Item No.
10009055), (CAT) (Item No. 707002) and (SOD) (Item
No. 706002). All assays were performed according to the
instruction manual of the manufacturers.
Histopathological assessment
The lower half of the right kidney was examined for histo-
pathological changes. All kidneys specimens were examined
under a light microscope. The kidneys were fixed in 10%
formalin and then embedded in paraffin wax before sec-
tioning at 5 μm thickness and stained with haematoxylin-
eosin and Masson’s trichrome stains. Kidney sections from
the six rats in each group were examined by two dependent
observers. Morphological analysis there were carried out
according to Houghton et al., [21] and were graded as fol-
lows: Grade 0 (normal), Grade 1 (when changes were lim-
ited to the tubulointerstitial areas of focal granulovascular
epithelial cell degeneration and granular debris in the tubu-
lar lumina with or without evidence of desquamation in
small foci (<1% of total tubule population involved by des-
quamation), Grade 2 (when tubular epithelial necrosis anddesquamation were easily seen but involved less than
half of the cortical tubules), Grade 3 (when more than
half of the proximal tubules showing necrosis and des-
quamation, but with intact tubules easily identified, and
Grade 4 (when there was complete or almost complete
proximal tubular necrosis).
Immunohistochemical study
For the quantitative determination of anti-p22 phox anti-
body, immunohistochemistry kit for p22 phox (CS9): sc-
130551 (Santa Cruz Biotechnology, INC.) was used. Briefly,
sections were deparaffinized in xylene and hydrated in a
series of graded alcohol. Deparaffinized sections were
treated in a microwave oven in a citrate buffer at 95°C for
15 minutes, and immersed in 3% hydrogen peroxide in
methanol for 10 min to abolish endogeneous peroxidase ac-
tivities. The sections were immersed in normal goat serum
for 15 min, incubated withmouse monoclonal antibody as a
marker for NADPH oxidase subunits (diluted to 1:50) at
37°C for 60 min, and then incubated with goat anti-mouse
IgG conjugated with horseradish\ peroxidise (HRP) (diluted
to 1:200). The reaction products were visualized using 3-
30-deiaminobenizidine tetrahydrochloride and hydrogen
peroxide. A cytoplasmic brown granule was marked as
positive expression of p22 phox.Statistical analysis
All data were expressed as mean ± standard error of the
mean (SEM) and statistical analysis was performed using
SPSS for Windows version 17.0 (SPSS Inc. Chicago, IL,
USA). One-way analysis of variance (ANOVA) followed
Table 3 Effects of VN on some in vivo antioxidant parameters in all experimental groups
Group CAT SOD MDA
(nmol/mg protein) (U/mg protein ) (nmol/mg protien)
Normal control 27.24 ± 34.32 32.23 ± 7.14 38.74 ± 2.61
TAA 21.57 ± 24.87* 22.3 ± 8.58* 107.14 ± 3.71*
VN100 + TAA 24.75 ± 105.09 26.73 ± 0.93** 78.85 ± 2.26**
VN300 + TAA 25.26 ± 56.01 27.47 ± 3.44** 54.35 ± 1.73**
Data were stated as mean ± SEM. Means with different superscripts are significantlydifferent. *P < 0.05 versus normal control group and **P < 0.05 versus TAA
control group.
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tically significant differences between groups at p < 0.05.Results
Gross pathology
During the course of this study, continuous daily adminis-
tration of 0.03% w/v TAA in drinking water was not associ-




Figure 1 Photomicrographs of renal sections in all experimental grou
with intact Bowman’s capsule (BM) and proximal convoluted tubules. Aii: N
group-Cortical area, showing swollen and necrotic tubular cells, inflammato
BM. C: VN 100 group- Cortical area exhibiting mild tubular epithelial chang
infiltration and GL look normal. D: VN 300 group - Cortical area, showing bkidneys from animals treated with TAA in drinking water
as well as VN-treated groups revealed a smooth, glistening
capsule with no petechial hemorrhage was noted.
Body and kidney weight
In the present study, the body weight of rats adminis-
tered with TAA were reduced significantly (p < 0.05) in
comparison to the normal control group. Although
there was increased in body weight of VN300 + TAAD
Aii
ps. Ai: Normal control-cortical area, showing normal glomeruli (GL)
ormal control-Medullary area, showing intact collecting ducts. B: TAA
ry cells infiltrate the GL and intertubular area and thinning-out of the
es with intratubular casts and mild intertubular inflammatory cells
oth GL and renal tubules appearing normal. H & E stain. Bar = 100 μm.
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was not significant (p < 0.05) compared to TAA group.
Concurrently, no noticeable concurrent significant dif-
ference in the weights of the kidneys for all groups was
shown (Table 1).
Biochemical determination
Rats from the TAA-treated group exhibited significantly
increased (p < 0.05) levels of blood urea and serum cre-
atinine compared to the normal control group. On the
other hand increases in these parameters were prevented
by concurrent treatment of animals with VN 100 mg/
kg, and more effectively, with VN 300 mg/kg which re-
sulted in nearly normalized levels of these parameters
(Table 2).
CAT and SOD are some of the enzymes of the intrinsic
antioxidant defense system [22] which are responsible for
the dissemination of free radicals such as superoxide radi-
cals. Table 3 shows that SOD was significantly (p < 0.05)
increased in high and low dose VN-treated groups but de-
creased in the TAA group due to long term excretion of
free radicals. Generally, rats treated only with TAA, had
significantly higher levels of MDA (p < 0.05) than normal
rats and the other experimental treated groups. Notably,
experimental rats treated with low dose and high dose VN
extract had significantly lower levels (p < 0.05) of renal
MDA compared to TAA group. These results suggest that





Figure 2 Photomicrographs of renal sections stained with Masson’s t
glomeruli (GL) in the cortical area, with intact Bowman’s capsule (BM) and
tissue with swollen and necrotic tubular cells, C: VN100 group, showing mi
showing renal cortical tissue with both GL and tubules appearing normal.Histopathological findings
Histopathological examination of sections from rat kidneys
treated with TAA showed impaired renal morphology
throughout with severe and generalized tubular epithelial
cell necrosis associated with diffuse tubular swelling,
glomerular congestion and inflammatory cell infiltration.
Kidneys from animals concurrently treated with VN 100
mg/kg body weight + TAA 0.03% in their drinking water
showed mild to moderate inflammatory cell infiltration and
tubular epithelial cell necrosis (Figure 1C), while concur-
rent treatment with VN 300 mg/kg body weight provided
the best morphological protection against TAA-induced
renal damage (Figure 1D and Figure 2D).
Discussion
Various useful drugs like acetaminophen, gentamicin
and some environmental and industrial toxicants can
cause severe renal damage through activation of these
drugs to highly reactive free radicals [23]. One of the most
extensively studied chemicals and industrial toxicants is
TAA. TAA is known to induce centrilobular hepatic ne-
crosis, liver cirrhosis, hepatocellular carcinoma and bile
duct proliferation [5,8,16,24,25] with injury to the terminal
portion of the proximal renal tubule [7]. After administra-
tion of TAA, this chemical undergoes an extensive metab-
olism forming sulfine (sulfoxide) and sulfene (sulfone).
Both are circulated through several vital organs in body
before finally being transformed into acetate and excreted
into urine within 24 hours [8].B
D
richrome of the different groups. A: Normal control, showing normal
proximal convoluted tubules. B: TAA group, showing renal cortical
ld tubular epithelial changes in renal cortical tissue. D: VN300 group,





Figure 3 Photomicrographs of renal sections for immunohistochemical evaluation of 22phox protein expression in all experimental
groups. A: Normal control, showing normal glomerulus (GL) in the cortical area, with intact Bowman’s capsule (BM) and normal
tubulointerstitium. B: TAA group showed p22phox was markedly expressed in glomerulus and interstitium, C: VN100 and D: VN300 groups,
showed marked reduction in p22phox protein expression. Bar = 50 μm.
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12 weeks found to cause renal toxicity as assessed by bio-
chemical analysis of urea and creatinine, MDA and anti-
oxidant status of SOD and CAT. As a measure of renal
function status, blood urea and creatinine are often
regarded as reliable markers [26]. The increased urea and
creatinine levels resulting from TAA administration in this
study (Table 2), are in agreement with a previous study
done by Begum et al., [2]. High values of blood urea and
serum creatinine indicate renal damage [27,28] and this
may be correlated with the significant and progressive
weight loss in the TAA group (Table 1). As for the VN100
and VN300 groups, although there was increased body
weight in both groups, the increase was not significantly
different compared in the TAA group (Table 1).
From this study, pretreatment with VN 100 mg/kg ex-
tract could partly prevent TAA-induced kidney damage
as shown by the decreasing levels of urea and creatinine.Table 4 Histopathological grading of the kidney sections
for all experimental groups
Pathological grading
Group N 0 I II III IV Average of grades
Normal 6 6 0 0 0 0 0.0**
TAA 6 0 0 0 2 4 3.33 ± 0.51*
VN 100 + TAA 6 0 1 1 4 0 2.00 ± 0.63**
VN 300 + TAA 6 1 3 2 0 0 1.16 ± 1.34**
Data were stated as mean ± SEM. Means with different superscripts are
significantly different. *P < 0.05 versus normal control group and **p < 0.05
versus TAA control group.These parameters were almost significantly normalized
by the administration of VN 300 mg/kg extract (Table 2).
This result is consistent with many previous studies
done using other traditional plants [29], and is strongly
attributed to the scavenging free radicals and reduced
lipid peroxidation mechanisms.
Free radicals are believed to play a major role in the de-
velopment of TAA-induced toxicity [30], hence, when oxi-
dative stress is overwhelming, the various inherent defense
mechanisms such as the antioxidant defense mechanisms,
intercellular concentration of CAT and SOD activities be-
come significantly impaired and insufficient [31]. This is
because during oxidative stress, the body uses its defense
mechanism to minimize the process of lipid peroxidation
using these antioxidant enzymes, thus, the activity of these
enzymes becomes higher in early stages of TAA induction.
When the oxidative insult was continued for a long period,
the enzymes become depleted and unable to fight against
the free radicals, suggesting advance stages of TAA-
induced peroxidation. This was evident in the present
study with the significant increase (p < 0.05) in MDA level,
renal damage in TAA group compared to the normal con-
trol group.
Several phytochemical studies have revealed the pres-
ence of volatile oils, lignans, flavonoid like flavones,
luteolin-7-glucoside and glycosides in VN [9]. In addition,
VN ethanolic extract possesses radical scavenging activity
probably due to higher concentration of flavonoids and al-
kaloids [32]. This was evident in the increased (CAT and
SOD) levels in this study as well as the decreased in MDA
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sumably, this is due to the antioxidant properties of the
plant extract, which may account for the nephroprotective
action of VN against TAA-induced nephrotoxicity experi-
mental models.
TAA is toxic to selected populations of cells (hepato-
cytes, proximal convoluted tubular cells in kidney and cor-
tical thymocytes) [7], and several animals studies have
shown that toxin-induced renal tubular damage plays a
crucial role in the reduction of glomerular filtration rate ei-
ther through obstruction and back leak of renal filtrate or
secondary to ROS [33]. The p22phox is one of the subunits
of the NADPH oxidase which generates ROS that plays an
important role in the development of many kidney diseases
[4,34]. Thus, VN is important in protecting the kidney
from TAA-induced injury, through the improvement in
renal function and antioxidant status. Furthermore, these
findings were corroborated by the renal histological and
immunohistochemical results, which revealed more exten-
sive and marked tubular and glomerular damage with ap-
parent expression of p22phox protein in the TAA-treated
group. Similar changes were also reported by Edward et al.,
[7] demonstrating structural changes in renal tissue. How-
ever, in the VN-treated groups, renal microscopic
changes were alleviated and the renal histological archi-
tecture was almost normalised, especially, at the maximum
dose of 300 mg/kg as shown in Figures 1, 2, 3 and Table 4.
Although the exact mechanism of TAA-induced neph-
rotoxicity is not well understood, but based on several
previous studies [27,28,35,36] we can postulate that the
protective effect of VN extract is via its antioxidant
and/or free radical scavenging activities due to its high
concentration of flavonoids and alkaloids content [9].
Conclusions
The overall results from this study demonstrated TAA-
induced renal injury by biochemical analysis, histopatho-
logical features and immunohistochemistry analysis. The
concurrent treatment with VN extract clearly provided a
considerable degree of protection in a dose-dependent
manner against the deleterious renal side effects of TAA.
In conclusion, VN could act on the kidney as a potent nat-
ural antioxidant to prevent ongoing TAA-induced nephro-
toxicity, thus, these results constitute a lead towards
discovering a novel herb in traditional and complementary
medicine.
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